Psychiatry & Neurology Doctors in Warrenton, VA Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Stephen A Reiter, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 340 Hospital Dr, Warrenton, VA 20186 Phone: 540-347-7620    Fax: 540-349-0644

Dr. Larry L Stephenson, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 440 Hospital Dr, Warrenton, VA 20186 Phone: 540-347-1600    Fax: 540-349-0902

Rahul Dewan, M.D. Psychiatry & Neurology - Sleep Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 Hospital Dr, Warrenton, VA 20186 Phone: 540-316-5540    Fax: 540-316-5580

Dr. Maria Nina Domingo Dunn, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 35 Horner St, Suite 200, Warrenton, VA 20186 Phone: 540-428-0060    Fax: 540-347-4803

Joseph Lee Krofcheck, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 4535 Den Haag Rd, Warrenton, VA 20187 Phone: 703-803-7793

Rana Kayal, M.D Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 384 Hospital Dr, Warrenton, VA 20186 Phone: 540-316-5980    Fax: 540-316-5583

News Archive

Physical and psychological factors contribute to somatic symptoms: Report

Patients with cancer who experience pain or depression also have a high rate of physical symptoms, such as fatigue, dry mouth and nausea, according to a report in the October 11 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

New research finds five different types of prostate cancer

New research has revealed that five different types of prostate cancer exist. How will this discovery change the outlook of prostate cancer screening? World renowned robotic prostate cancer surgeon, Dr. David Samadi, evaluates.

FDA approves Horizon Pharma's RAYOS to treat key IL-6 mediated diseases

Horizon Pharma, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved RAYOS (prednisone) delayed-release tablets (1 mg, 2 mg and 5 mg) to treat a broad range of diseases including rheumatoid arthritis (RA), polymyalgia rheumatica (PMR), psoriatic arthritis (PsA), ankylosing spondylitis (AS), asthma and chronic obstructive pulmonary disease (COPD).

Study confirms defect in sweat gland function as disease biomarker for XLHED

Edimer Pharmaceuticals, a biotechnology company focused on developing an innovative therapy for the rare genetic disorder, X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), today announced key findings of a study exploring novel approaches to the assessment of sweat function in males with XLHED. Affected individuals lack a normal sweat response, placing them at life-long risk for clinically-significant hyperthermia.

Study looks at ways to reduce prescription drugs linked to fracture risk among older adults

Fragility fractures - those that occur at standing height - are a significant source of sickness and death among the elderly population in the United States. They are also associated with annual direct costs of over $16 billion.

Read more Medical News

› Verified 2 days ago